Repligen Corporation(NASDAQ:RGEN) 
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography r...
Website: http://www.repligen.com
Founded: 1981
Full Time Employees: 761
Sector: Healthcare
Industry: Medical Instruments & Supplies
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 117.72
H 118.42
L 106.78
C 111.94
V 1,818,774
10EMA 111.94
20EMA 111.94
60EMA 111.94
120EMA 111.94
250EMA 111.94